Arbit Ehud
Emisphere Technologies, Inc., Tarrytown, New York 10591, USA.
Diabetes Technol Ther. 2004 Aug;6(4):510-7. doi: 10.1089/1520915041705929.
Insulin remains the most effective and durable drug in the armamentarium for the treatment of advanced-stage diabetes. Nevertheless, clinical studies have shown that even on insulin treatment, a significant percentage of patients fail to attain lasting glycemic control. Well-recognized reasons for this failure include issues related to patients' noncompliance with an injectable drug and the late stage at which insulin is prescribed, but less explicit reasons related to the nonphysiological way insulin is currently administered are equally important. Parenteral insulin targets peripheral tissue rather than the liver with pharmacokinetics that do not replicate the normal dynamics of endogenous insulin release. Oral insulin is one of several alternative methods of insulin administration that are in clinical stages of development. The oral route of insulin delivery takes advantage of the portal-hepatic route of absorption. A review of relevant physiology is herewith provided.
胰岛素仍然是治疗晚期糖尿病的药物库中最有效、最持久的药物。然而,临床研究表明,即使接受胰岛素治疗,仍有相当比例的患者未能实现持久的血糖控制。导致这种失败的公认原因包括患者不遵守注射药物治疗以及胰岛素处方时疾病已处于晚期,但与目前胰岛素非生理性给药方式相关的不太明确的原因同样重要。肠外胰岛素作用于外周组织而非肝脏,其药代动力学无法复制内源性胰岛素释放的正常动态过程。口服胰岛素是几种处于临床开发阶段的胰岛素给药替代方法之一。口服胰岛素给药途径利用了门静脉 - 肝脏吸收途径。特此提供相关生理学综述。